Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 6—June 2008

Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries

Hitoshi Oshitani*Comments to Author , Taro Kamigaki*, and Akira Suzuki*
Author affiliations: *Tohoku University Graduate School of Medicine, Sendai, Japan;

Main Article

Table 1

Cost of purchasing oseltamivir to cover 25% of population with regard to total health expenditure in countries with different economic status*

Category of country Average GNP, per capita† Average annual health expenditure, per capita† Cost of 1 treatment course of oseltamivir, 
% annual health expenditure
High income 30,168 3,376 0.11
Upper middle income 4,310 280 1.34
Lower middle income 1,364 77 4.87
Low income 753 29 12.93

*Data obtained from World Health Organization website ( GNP, gross national product.
†In US$.

Main Article

Page created: July 09, 2010
Page updated: July 09, 2010
Page reviewed: July 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.